...
首页> 外文期刊>Mutation Research: International Journal on Mutagenesis, Chromosome Breakage and Related Subjects >Is the tissue persistence of O(6)-methyl-2'-deoxyguanosine an indicator of tumour formation in the gastrointestinal tract?
【24h】

Is the tissue persistence of O(6)-methyl-2'-deoxyguanosine an indicator of tumour formation in the gastrointestinal tract?

机译:O(6)-甲基-2'-脱氧鸟苷的组织持久性是否是胃肠道肿瘤形成的指标?

获取原文
获取原文并翻译 | 示例
           

摘要

Azoxymethane (AOM) is a methylating agent capable of inducing mutations in DNA by forming adducts with DNA bases. It has been used to understand the mechanisms involved in colon carcinogenesis. Of the adducts formed in response to AOM, O(6)-methyl-2'-deoxy-guanosine (O(6)-mdGua) is the most mutagenic. Based on studies in rodents of the abundance and persistence of DNA adducts in various tissues after treatment with alkylating agents, previous results suggest, as a generalization, that the longer O(6)-mdGua adducts remain unrepaired in the cells of a tissue, the greater the risk for tumorigenesis. To test this hypothesis, we have built on these studies, expanding the number of tissues in which O(6)-mdGua abundance and persistence were examined and correlating these data with tumour distribution and abundance in rats maintained for 26 weeks after the treatment with AOM. Our study revealed firstly the existence of groups of tissues that developed relatively large amounts (proximal and distal colon, proximal small intestine (SI), liver and kidney) and relatively low levels (stomach, distal SI, bladder, spleen, blood and lung) of O(6)-mdGua after AOM exposure. Secondly, while all tissues showed an increase in adduct levels at 6h after mutagen treatment and most showed a significant drop in adduct levels between 6h and 48h (stomach, proximal and distal SI, liver, spleen, blood and lung), one group of tissues displayed O(6)-mdGua levels that did not decrease at 48h (proximal and distal colon, kidney and bladder). Predictably, the colon displayed tumours 26 weeks after treatment. Interestingly, however, the proximal SI also displayed significant tumour formation at that time. Our findings demonstrate (1) a direct association between exposure to O(6)-mdGua and tumours of the distal colon and (2) a dissociation of the relationship between adduct clearance and tumorigenesis in the SI. This diversity of response in the gastrointestinal tract warrants further analysis.
机译:乙氧基甲烷(AOM)是一种甲基化剂,能够通过与DNA碱基形成加合物来诱导DNA突变。它已被用来了解结肠癌发生的机制。在响应AOM形成的加合物中,O(6)-甲基-2'-脱氧鸟苷(O(6)-mdGua)最具致突变性。根据啮齿类动物对烷基化剂处理后各种组织中DNA加合物的丰度和持久性的研究,以前的结果普遍认为,较长的O(6)-mdGua加合物在组织细胞中仍未修复,因此发生肿瘤的风险更大。为了验证这一假设,我们在这些研究的基础上,扩大了检查O(6)-mdGua丰度和持久性的组织数量,并将这些数据与AOM治疗后维持26周的大鼠的肿瘤分布和丰度相关联。我们的研究首先揭示了存在相对大量组织(近端和远端结肠,近端小肠(SI),肝和肾)和相对较低水平(胃,远端SI,膀胱,脾脏,血液和肺脏)的组织组的存在。 AOM暴露后的O(6)-mdGua值。其次,虽然所有组织在诱变剂处理后6h均显示出加合物水平增加,并且大多数组织在6h至48h之间(胃,近端和远端SI,肝脏,脾脏,血液和肺部)的加合物水平显着下降,但一组组织显示O(6)-mdGua水平在48小时(近端和远端结肠,肾脏和膀胱)未降低。可以预计,治疗后26周结肠显示出肿瘤。然而,有趣的是,当时的近端SI也显示出明显的肿瘤形成。我们的发现表明(1)暴露于O(6)-mdGua与远端结肠肿瘤之间存在直接关联,(2)加合物清除与SI中肿瘤发生之间关系的分离。胃肠道反应的多样性需要进一步分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号